Mitochondrial Dysfunction: Potential Therapy For Abdominal Aortic Aneurysms.

Area of Science:

• Vascular Biology
• Mitochondrial Medicine
• Cardiovascular Research

Background:

• Abdominal Aortic Aneurysm (AAA) is a critical vascular condition with ongoing research into its pathogenesis.
• Despite progress, substantial knowledge gaps remain regarding the molecular mechanisms driving AAA.
• Emerging evidence highlights mitochondrial dysfunction as a key factor in AAA development and severity.

Purpose of the Study:

• To review current research on AAA pathogenesis.
• To focus on the role of mitochondrial dysfunction in AAA.
• To explore potential therapeutic strategies targeting mitochondrial function for AAA.

Main Methods:

• Comprehensive literature review of recent findings on AAA pathogenesis.
• Analysis of studies investigating mitochondrial dysfunction in AAA.
• Synthesis of information on mitochondrial quality control, membrane potential, morphology, redox balance, respiratory chain function, mutations, and signaling pathways.

Main Results:

• Mitochondrial dysfunction exacerbates AAA, leading to increased expansion, rupture, and mortality.
• Key aspects of mitochondrial dysfunction in AAA include impaired quality control, altered membrane potential, morphological changes, oxidative stress, and respiratory chain defects.
• Mitochondrial mutations and dysregulated signaling pathways are implicated in AAA progression.

Conclusions:

• Mitochondrial dysfunction is a critical contributor to abdominal aortic aneurysm pathogenesis.
• Understanding these mitochondrial mechanisms provides a basis for novel therapeutic interventions.
• Regulating mitochondrial function presents a promising avenue for AAA treatment and prevention.